Future of oral iron chelator deferiprone. (L1) ICOC committee. 1993

G J Kontoghiorghes, and M B Agarwal, and P Tondury, and M J Kersten, and M Jaeger, and G Vreugdenhil, and A Vania, and Y E Rahman

UI MeSH Term Description Entries
D007502 Iron Chelating Agents Organic chemicals that form two or more coordination links with an iron ion. Once coordination has occurred, the complex formed is called a chelate. The iron-binding porphyrin group of hemoglobin is an example of a metal chelate found in biological systems. Iron Chelates,Agents, Iron Chelating,Chelates, Iron,Chelating Agents, Iron
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077543 Deferiprone A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA. 1,2-Dimethyl-3-hydroxy-4-pyridinone,1,2-Dimethyl-3-hydroxypyrid-4-one,1,2-Dimethyl-3-hydroxypyridin-4-one,3-Hydroxy-1,2-dimethyl-4-pyridinone,DMOHPO,Ferriprox,HDMPP,1,2 Dimethyl 3 hydroxy 4 pyridinone,1,2 Dimethyl 3 hydroxypyrid 4 one,1,2 Dimethyl 3 hydroxypyridin 4 one,3 Hydroxy 1,2 dimethyl 4 pyridinone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015913 Chelation Therapy Therapy of heavy metal poisoning using agents which sequester the metal from organs or tissues and bind it firmly within the ring structure of a new compound which can be eliminated from the body. Therapy, Chelation,Chelation Therapies,Therapies, Chelation

Related Publications

G J Kontoghiorghes, and M B Agarwal, and P Tondury, and M J Kersten, and M Jaeger, and G Vreugdenhil, and A Vania, and Y E Rahman
June 1993, Lancet (London, England),
G J Kontoghiorghes, and M B Agarwal, and P Tondury, and M J Kersten, and M Jaeger, and G Vreugdenhil, and A Vania, and Y E Rahman
June 1993, Lancet (London, England),
G J Kontoghiorghes, and M B Agarwal, and P Tondury, and M J Kersten, and M Jaeger, and G Vreugdenhil, and A Vania, and Y E Rahman
August 1996, Pharmacy world & science : PWS,
G J Kontoghiorghes, and M B Agarwal, and P Tondury, and M J Kersten, and M Jaeger, and G Vreugdenhil, and A Vania, and Y E Rahman
February 1995, British journal of haematology,
G J Kontoghiorghes, and M B Agarwal, and P Tondury, and M J Kersten, and M Jaeger, and G Vreugdenhil, and A Vania, and Y E Rahman
December 2000, Transfusion science,
G J Kontoghiorghes, and M B Agarwal, and P Tondury, and M J Kersten, and M Jaeger, and G Vreugdenhil, and A Vania, and Y E Rahman
November 1997, The Journal of surgical research,
G J Kontoghiorghes, and M B Agarwal, and P Tondury, and M J Kersten, and M Jaeger, and G Vreugdenhil, and A Vania, and Y E Rahman
September 1994, Vnitrni lekarstvi,
G J Kontoghiorghes, and M B Agarwal, and P Tondury, and M J Kersten, and M Jaeger, and G Vreugdenhil, and A Vania, and Y E Rahman
June 1993, The Journal of the Association of Physicians of India,
G J Kontoghiorghes, and M B Agarwal, and P Tondury, and M J Kersten, and M Jaeger, and G Vreugdenhil, and A Vania, and Y E Rahman
April 1993, Lancet (London, England),
G J Kontoghiorghes, and M B Agarwal, and P Tondury, and M J Kersten, and M Jaeger, and G Vreugdenhil, and A Vania, and Y E Rahman
April 1993, Lancet (London, England),
Copied contents to your clipboard!